Skolkovo funds personalized oncology project

Skolkovo funds personalized oncology projectThe Skolkovo Foundation has announced plans to fund a Russian project team developing a system to automate diagnostics and treatment in personalized oncology therapy

The Skolkovo Foundation has unveiled plans to fund a Russian project team developing a system to automate diagnostics and treatment in personalized oncology therapy, Nanonewsnet.ru reported. The company behind the effort is RosGenDiagnostika, a start-up growing in the Severny biopharma cluster in Moscow. The project is aimed at automating genetic diagnostics procedures and selecting the best possible therapies, taking into account each patient?s individual features. The system calls for the development of what the project owners claim will be a ?unique? database of all biotracers and markers available in the market, indicating their stability and resistance to existing cancer drugs. As the project unfolds, RosGenDiagnostika hopes to develop and commercialize a special diagnostics platform, ?unparalleled elsewhere in the world,? which would enable physicians to offer patients the most suitable therapies based on analyzing genetic and expression biomarkers...





https://www.venture-news.ru/ipo-news/64680-mozhno-li-vyigrat-v-kazino-vsya-pravda-kotoraya-shokiruet-kazhdogo.html